Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cystic fibrosis
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
2
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
2
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
abbvie
allergan aesthetics
alnylam pharmaceuticals
alzheimer's disease
ambys medicines
amgen
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
astrazeneca
athenex
What
bio
drug
2
×
moves
2
×
roundup
2
×
acquisitions
aren’t
biggest
build
buy
ceo
company’s
daniel
debut
developers
drugs
dyne’s
fda
gene
gilead
help
imminent
long
medicare
microbiome
news
noteworthy
openly
o’day
patients
pipeline
prices
road
rulings
sciences
scores
seagen
separate
spoken
therapy
they’ll
Language
unset
Current search:
roundup
×
drug
×
national
×
moves
×
" raleigh-durham blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More